Humana Inc.’s Stock Price Plummets to $361.61, Recording a Steep 10.61% Decline

Humana Inc. (HUM)

361.61 USD -42.91 (-10.61%) Volume: 4.38M

Humana Inc.’s stock price stands at 361.61 USD, witnessing a sharp decline of 10.61% in this trading session with a trading volume of 4.38M. The healthcare giant has experienced a year-to-date (YTD) decrease of 21.01%, reflecting a challenging market performance.

Latest developments on Humana Inc.

Humana Inc.’s stock price took a hit today after the company warned of higher hospital admissions, leading to a dip despite beating quarterly profit estimates under the new CEO’s leadership. The healthcare insurance company reported revenue and adjusted profit that surpassed analyst expectations, but still experienced a decline in stock value. Humana also expects to lose a significant number of Medicare Advantage members next year, impacting their financial outlook. With rising medical costs and a revised annual earnings forecast, investors are closely monitoring the company’s performance amidst the changing healthcare landscape.

Humana Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma have published insightful reports on Humana Inc. The first report, titled “Humana Inc.: Enhanced Strategic Management of Benefit Costs and Member Acquisition Tactics! – Major Drivers,” discusses the company’s mixed first-quarter results for 2024 and adjusted expectations for the upcoming year. Humana has reaffirmed its full-year adjusted EPS guidance and increased its membership growth outlook, showcasing operational resilience and strategic expansions. The second report, “Humana Inc.: Impacts on Pharmacy Benefit Managers (PBMs) Resulting From IRA Changes & Other Major Drivers,” highlights CEO Bruce Broussard’s positive remarks on the company’s financial performance and future outlook during a Q&A session following the earnings call.

A look at Humana Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. has received a positive overall outlook from Smartkarma Smart Scores, with a solid score across the board in key factors such as Value, Dividend, Growth, Resilience, and Momentum. This indicates a promising long-term outlook for the managed health care company. With a balanced score in these areas, Humana is positioned well to continue providing coordinated health care services to its members in the United States and Puerto Rico.

As a company that offers health maintenance organizations, preferred provider organizations, and administrative services products, Humana serves a diverse range of customers including employer groups, government-sponsored plans, and individuals. With its strong scores in various aspects, including Momentum, Humana Inc. is well-equipped to navigate the challenges of the healthcare industry and maintain its position as a leading provider of managed health care services.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma